12h
Pharmaceutical Technology on MSNEli Lilly pledges $630m on OliX’s Phase I RNA candidate for MASHLilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.
M*A*S*H followed the staff at the United States Army Mobile Army Surgical Hospital (MASH) in the midst of the Korean War and ...
French biotech Inventiva’s layoffs and pipeline shift are expected to help keep the company operational into the second half ...
11d
Everyday Health on MSNObesity and MASH: What You Should KnowIf you have obesity, losing even a little weight helps not only improve your overall health, but also prevent liver issues ...
3d
Tasting Table on MSN11 Ingredients To Elevate Instant Mashed PotatoesIf you're making boxed mashed potatoes, there's no reason to keep it plain. There are a few easy ways to you can elevate ...
Eli Lilly strengthens its pipeline with AdvanCell for targeted alpha therapies and partners with OliX to advance OLX75016 for ...
11d
Everyday Health on MSN7 Things People With Diabetes Should Know About MASHIf you have diabetes, taking steps to manage it can help prevent related health issues, including MASH. Here’s what to know ...
Why have drugs to treat the liver disease MASH reached a tipping point? How did Hims & Hers convince Childish Gambino to ...
Viking Therapeutics got the market's attention with robust phase 2 results for VK2735, a potential weight loss therapy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results